These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20021229)

  • 21. Lyotropic liquid crystal systems in drug delivery.
    Guo C; Wang J; Cao F; Lee RJ; Zhai G
    Drug Discov Today; 2010 Dec; 15(23-24):1032-40. PubMed ID: 20934534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil.
    Richards H; Thomas CP; Bowen JL; Heard CM
    J Pharm Pharmacol; 2006 Jul; 58(7):903-8. PubMed ID: 16805949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel.
    Hosmer JM; Shin SH; Nornoo A; Zheng H; Lopes LB
    J Pharm Sci; 2011 Apr; 100(4):1444-55. PubMed ID: 20957759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, characterization, and in vitro release of new transdermal methimazole as alternative to oral delivery.
    Morales ME; Clarés B; López-Viota M; Ruiz MA
    Drug Deliv; 2009 Jan; 16(1):1-10. PubMed ID: 19555302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
    Rajabalaya R; Musa MN; Kifli N; David SR
    Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-layer transdermal film containing lidocaine: modulation of drug release.
    Padula C; Nicoli S; Colombo P; Santi P
    Eur J Pharm Biopharm; 2007 Jun; 66(3):422-8. PubMed ID: 17196804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical characterization of PEG1500-12-acyloxy-stearate micelles and liquid crystalline phases.
    McNamee CE; Nilsson M; von Corswant C; Söderman O
    Langmuir; 2005 Aug; 21(18):8146-54. PubMed ID: 16114915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition.
    El Maghraby GM
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):595-600. PubMed ID: 19892531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation.
    Savić SD; Savić MM; Vesić SA; Vuleta GM; Müller-Goymann CC
    Int J Pharm; 2006 Aug; 320(1-2):86-95. PubMed ID: 16730932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal Cubic Phases of Metformin Hydrochloride: In Silico and in Vitro Studies of Delivery Mechanisms.
    Yu X; Jin Y; Du L; Sun M; Wang J; Li Q; Zhang X; Gao Z; Ding P
    Mol Pharm; 2018 Aug; 15(8):3121-3132. PubMed ID: 29979604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation and structural determination of lyotropic lamellar liquid crystalline systems of pharmaceutical importance]].
    Makai M; Csányi E; Erös I; Dékány I
    Acta Pharm Hung; 2003; 73(2):71-6. PubMed ID: 14702685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by Poloxamer 407 in water.
    Ivanova R; Lindman B; Alexandridis P
    J Colloid Interface Sci; 2002 Aug; 252(1):226-35. PubMed ID: 16290783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray diffraction studies on mesophases of cetyl- and dodecyltrimethylammoniumbromide in liquid ammonia.
    Bzik S; Jansen M
    Chemistry; 2003 Feb; 9(3):613-20. PubMed ID: 12569452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyotropic liquid crystal preconcentrates for the treatment of periodontal disease.
    Fehér A; Urbán E; Eros I; Szabó-Révész P; Csányi E
    Int J Pharm; 2008 Jun; 358(1-2):23-6. PubMed ID: 18403142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.